Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8593383 | 0.90 | TBXA2R (0.67) | TBXA2RTBXAS1 | |
| SCHEMBL8595578 | 0.87 | TBXAS1 (0.77) | TBXA2RTBXAS1 | |
| SCHEMBL8593101 | 0.87 | TBXA2R (0.64) | TBXA2RTBXAS1 | |
| SCHEMBL8592974 | 0.87 | TBXA2R (0.64) | TBXA2RTBXAS1 | |
| SCHEMBL8593398 | 0.86 | TBXAS1 (0.52) | TBXA2RTBXAS1 | |
| SCHEMBL8592982 | 0.84 | TBXAS1 (0.70) | TBXA2RTBXAS1 | |
| SCHEMBL8594726 | 0.84 | TBXA2R (0.65) | TBXA2RTBXAS1 | |
| SCHEMBL8593839 | 0.83 | TBXAS1 (0.71) | TBXA2RTBXAS1 | |
| SCHEMBL14327858 | 0.81 | TBXA2R (1.00) | TBXA2RTBXAS1 | |
| SCHEMBL9130164 | 0.81 | TBXA2R (0.81) | TBXA2RTBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1037176-C | Benzenealkanoic acids for cardiovascular diseases | PFIZER RES & DEV (IE) | 1998-01-28 | — | — | CN | disclosed |
| EP-0662950-B1 | BENZENEALKANOIC ACIDS FOR CARDIOVASCULAR DISEASES | PFIZER LTD (GB) | 1998-01-14 | — | — | EP | disclosed |
| US-5618941-A | Benzenealkanoic acids for cardiovascular diseases | PFIZER INC. (US) | 1997-04-08 | — | — | US | disclosed |
| EP-0662950-A1 | BENZENEALKANOIC ACIDS FOR CARDIOVASCULAR DISEASES | Pfizer Limited (GB) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994006761-A1 | BENZENEALKANOIC ACIDS FOR CARDIOVASCULAR DISEASES | PFIZER LIMITED (GB) | 1994-03-31 | — | — | WO | disclosed |